Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Defactinib
Ovarian Serous Adenocarcinoma
Verastem, Inc.P3BB (66)
Denosumab
Breast Carcinoma
Washington University School of MedicineP3BB (66)
Deucrictibant
Hereditary Angioedema Type 3
Pharvaris Netherlands B.V.P3BB (66)
Dexasone
Metastatic Malignant Neoplasm
GenmabP3BB (66)
Dexasone
Smoldering Plasma Cell Myeloma
Regeneron PharmaceuticalsP3BB (66)
Dexasone
Neoplasm
Hellenic Society of HematologyP3BB (66)
Dexmedetomidine
Bipolar I Disorder
BioXcel Therapeutics IncP3BB (66)
Dexmedetomidine
Bipolar II Disorder
BioXcel Therapeutics IncP3BB (66)
Divozilimab
Multiple Sclerosis
BiocadP3BB (66)
Docetaxel
Lung Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3BB (66)
Docetaxel
Non-Small Cell Squamous Lung Carcinoma
Shanghai Henlius BiotechP3BB (66)
Docetaxel
Lung Large Cell Carcinoma
Korean South West Oncology GroupP3BB (66)
Docetaxel
Urothelial Carcinoma
NuCana plcP3BB (66)
Dostarlimab
Non-Small Cell Lung Carcinoma
GlaxoSmithKlineP3BB (66)
Droxidopa
Multiple System Atrophy
Loma Linda UniversityP3BB (66)
Durvalumab
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P3BB (66)
Durvalumab
Small Cell Lung Carcinoma
PrECOG, LLC.P3BB (66)
Elacestrant
Breast Cancer
iOMEDICO AGP3BB (66)
Elacestrant
Estrogen-Receptor Positive Breast Cancer
Kristina A. FanucciP3BB (66)
Epirubicin
Biliary Tract Cancer
Merck Sharp & Dohme LLCP3BB (66)
Epirubicin
Head And Neck Cancer
Thomas Jefferson UniversityP3BB (66)
Epirubicin
HER2 Positive Breast Carcinoma
Ohio State University Comprehensive Cancer CenterP3BB (66)
Equine Atg
Disease Related To Hematopoietic Stem Cell Transplant
DKMS gemeinnützige GmbHP3BB (66)
Etavopivat
Thalassemia
Novo Nordisk A/SP3BB (66)
Etoposide
Lung Adenocarcinoma
Guangdong Association of Clinical TrialsP3BB (66)
Showing 2476 to 2500 of 42,301 assets
PreviousPage 100 of 1693Next